Načítá se...
EFFICACY AND SAFETY OF TREATMENT OF HEPATITIS C IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
BACKGROUND & AIMS: There is uncertainty about the efficacy and safety of treatment for hepatitis C virus (HCV) infection in patients with inflammatory bowel disease (IBD). IBD can become exacerbated during treatment with interferon (IFN) and serious adverse events, such as pancytopenia or hepato...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3846435/ https://ncbi.nlm.nih.gov/pubmed/23891915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2013.07.014 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|